Treatment of Prostatitis
For acute bacterial prostatitis (ABP), treat with broad-spectrum antibiotics according to systemic UTI guidelines for 2-4 weeks; for chronic bacterial prostatitis (CBP), prescribe fluoroquinolones (ciprofloxacin or levofloxacin) as first-line therapy for 4-6 weeks, with alternative agents (doxycycline, azithromycin, or metronidazole) reserved for specific intracellular or atypical pathogens. 1
Acute Bacterial Prostatitis (ABP)
Diagnostic Approach
- Do NOT perform prostatic massage in suspected ABP (strong recommendation) 1
- Obtain mid-stream urine dipstick checking for nitrites and leukocytes 1
- Collect mid-stream urine culture to guide antibiotic selection 1
- Draw blood cultures and complete blood count in all presenting patients 1
- Consider transrectal ultrasound in selected cases to exclude prostatic abscess 1
Treatment Strategy
Initial therapy: Parenteral administration of high-dose bactericidal antimicrobials is recommended for severely ill patients 1:
- Broad-spectrum penicillins (e.g., piperacillin-tazobactam)
- Third-generation cephalosporins (e.g., ceftriaxone)
- Fluoroquinolones (e.g., ciprofloxacin)
- Consider adding an aminoglycoside for combination therapy 1
Duration: 2-4 weeks total, with transition to oral therapy after normalization of infection parameters 1, 2
Success rate: 92-97% when appropriate antibiotics prescribed for adequate duration 2
Critical Management Points
- Approximately 10% of patients develop urinary retention requiring catheterization (suprapubic preferred over urethral to reduce risk of chronic bacterial prostatitis) 1
- Prostatic abscess management depends on size: <1 cm diameter may respond to conservative treatment; larger abscesses require aspiration or continuous drainage 1
- Enterobacteriaceae (E. coli, Klebsiella, Pseudomonas) cause 80-97% of cases 2
Chronic Bacterial Prostatitis (CBP)
Diagnostic Approach
- Perform Meares-Stamey 2- or 4-glass test (strong recommendation) 1, 3
- Conduct accurate microbiological evaluation for atypical pathogens including Chlamydia trachomatis and Mycoplasma 1
- Do NOT routinely use ejaculate analysis alone for diagnosis 1
- Consider transrectal ultrasound in selected cases 1
First-Line Treatment
Fluoroquinolones are the recommended first-line agents (strong recommendation) 1:
- Ciprofloxacin or levofloxacin at optimal oral daily dose
- Duration: 4-6 weeks minimum 1, 2
- Rationale: Favorable pharmacokinetic properties with excellent prostatic penetration, activity against Gram-negative pathogens including Pseudomonas aeruginosa and C. trachomatis 1
Alternative Agents for Specific Pathogens
For intracellular bacteria (C. trachomatis, Mycoplasma) (strong recommendation) 1:
For Trichomonas vaginalis (strong recommendation) 1:
- Metronidazole: 500 mg three times daily for 14 days 1
Important Considerations
- Up to 74% of CBP cases are due to Gram-negative organisms, particularly E. coli 2
- Growing antimicrobial resistance to fluoroquinolones poses significant clinical challenges 4
- Approximately 10% of ABP cases progress to CBP 4
- Prolonged therapy (minimum 4 weeks, up to 12 weeks) may be necessary for refractory cases 5
Common Pitfalls and Caveats
Avoid These Errors:
- Performing prostatic massage in ABP - This is contraindicated and can precipitate bacteremia 1
- Inadequate treatment duration - CBP requires minimum 4-6 weeks; shorter courses lead to recurrence 1, 5
- Using ejaculate culture alone - This is unreliable for CBP diagnosis 1
- Ignoring atypical pathogens - Always test for Chlamydia and Mycoplasma in CBP, as these require different antibiotics 1
Key Clinical Distinctions:
- ABP presents acutely with fever, malaise, voiding symptoms, and poorly localized pelvic pain 1
- CBP presents with symptoms ≥3 months including recurrent UTIs from the same bacterial strain, pelvic/perineal pain, and lower urinary tract symptoms 2, 3
- The causative organisms differ: ABP is predominantly Enterobacteriaceae, while CBP has broader spectrum including atypical organisms 1
Antibiotic Selection Principles:
Effective prostatic penetration requires antibiotics with 6:
- High lipid solubility
- Low degree of ionization
- High dissociation constant
- Low protein binding
- Small molecular size
This explains why fluoroquinolones are preferred over beta-lactams for CBP despite both having activity against typical uropathogens 1, 6.